Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported band not used
Founded
2022
4 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Bay Pharma, founded with a strong vision for the future of pharmaceutical innovation, is a pioneering supplier of pharmaceutical-grade therapeutic vaporised nicotine products. Our company operates at the intersection of cutting-edge research and rigorous safety standards, ensuring our offerings are always of the highest calibre. With an unwavering commitment to health, safety, and quality, we are proudly compliant with the Therapeutic Goods Administration (TGO-110) Standards, a testament to our dedication to excellence.
Our product portfolio, robustly designed to meet the needs of our Australian customer base, centres on vaporised nicotine products formulated to the highest pharmaceutical standards. Leveraging scientific knowledge and advanced technologies, we deliver nicotine solutions that meet the rigorous demands of the pharmaceutical industry.
It's critical to note that Bay Pharma is wholly independent. We stand apart from the tobacco industry and are committed to establishing a health-focused future that rises above traditional nicotine delivery methods.
Bay Pharma manufactures and distributes NVP products with the primary focus of enabling 2.2 million Australian smokers reduce the harms caused by smoking and to quit.
Over 70% of Australian smokers would like to quit but are either unable or unwilling. Bay Pharma offers viable alternatives that allow smokers to reduce the harms associated with smoking.
Bay Pharma products are manufactured the highest quality standards and exceeds the requirement in Australia.
We recognise that while these products can help achieve the goal of a smoke-free Australia, they should not be accessible to youth or non-smokers.
The team at Bay Pharma is committed to helping improve smoking cessation rates nationwide and will continue to work in collaboration with medical, scientific and public health stakeholders to ensure that we stay at the very forefront of therapeutic NVP technology and innovation.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUlevel 4, 55 Clarence Street; Sydney, NSW 2000Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at BayPharma?
5 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does BayPharma have offices?
One address on record, Australia only. Primary: level 4, 55 Clarence Street, Sydney, NSW 2000.
Has BayPharma raised funding?
None linked to this brand.
Which companies are listed alongside BayPharma?
Six peer profiles on record: Fonterra and Wild by Instinct.